NBIX

NEUROCRINE BIOSCIENCES INC

NasdaqAdd to watchlist

Healthcare · Drug Manufacturers—Specialty & Generic

$156.57

+$1.43+0.92%

Delayed · 2026-09-10T20:00:00.000Z · marketstack

2 of 47tracked managers hold this· Q2 2026

Aug 12, 2026$156.57

+$0.08+0.05%over 1M

Day range57% of range

$152.04$159.93

Session

Previous close: $155.14
Open: $154.38
Volume: 895.19K
Avg volume: -
Day high: $159.93
Day low: $152.04

Fundamentals

Visualize fundamentals and more

Market cap: 15.81B
P/E ratio: 23.12
EPS (TTM): $6.77
Dividend yield: -
Beta: 0.37
Shares outstanding: 101M

Source SEC EDGAR · 9/11/2026

Tracked investors

As of Q2 2026 · 74 days ago · next update ~14 Nov 2026· what moved this quarter, onMeasure

2 fund managers this platform follows disclosed a position in NBIX, from quarterly SEC filings up to 45 days old; a manager may have sold since without yet having to say so.

Dodge & Cox
Dodge & Cox
$941.22M
0.49%of book
Joel Greenblatt
Gotham Asset Management
$62.62M
0.15%of book

Manager	Position	Share of their book	Last change
Dodge & Cox Dodge & Cox	$941.22M	0.49%
Joel Greenblatt Gotham Asset Management	$62.62M	0.15%

Share price, with each quarter a tracked manager’s position changed shaded across the range it traded in.

90120150180

157

now

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Q4 '25

Q1 '26

Q2 '26

Hover a shaded quarter to see it moved. Who, and the range they traded in, is onBespoke

13F filings cover US-listed shares only (not cash, bonds, shorts, or private holdings) and are never a recommendation to do the same.

Risk factors, year on year

Item 1AFebruary 2026 10-KFebruary 2025as filed.

added: 50
dropped: 24
re-drafted: 41

Out of 211 passages in this year’s Item 1A.

The assistant has not been given these passages. It will say so, and say what opens them. This costs you no question.

New this year

• Our investigational treatments for potential use in neurology, psychiatry, endocrinology, obesity and related metabolic diseases, and immunology may in the future compete with numerous approved products and development-stage programs being pursued by …

73 more passages, included withBespoke

Recent activity

19 more events, included withMeasure

Discussion

No comments yet

Set a username to join the discussion. It’s the only thing shown next to what you post, never your email address.

Comments are written by other users. Nothing here is investment advice and nothing is checked for accuracy.

Companies like NEUROCRINE BIOSCIENCES INC

Also filed under Drug Manufacturers, ranked by how closely they sit beside NBIX.

LLYELI LILLY & Co
JNJJOHNSON & JOHNSON
AMGNAMGEN INC
MRKMerck & Co., Inc.
ABBVAbbVie Inc.
PFEPFIZER INC

Ask about NEUROCRINE BIOSCIENCES INC

The assistant answers from what NBIX has actually filed: 17 annual reports filed with the SEC, 172 Form 4 filings from the last year, 13F positions from the 2 tracked investors who hold it and 4 funds that hold it. Every figure in a reply links to the filing it came from, so an answer can be checked rather than believed.

Pressing one answers it here, from NBIX's filings and figures. One a day without an account; a free account has its own, and no card.

See every investor holding NEUROCRINE BIOSCIENCES INC, and every quarter they moved.

Ten seconds, no card, and nothing to cancel.

What an account lets you do with NEUROCRINE BIOSCIENCES INC

Separate the decisions from the paperwork
Every Form 4 NBIX insiders have filed, with vesting and automatic tax sales struck out: what's left is the buys and sells somebody actually chose to make.
Every filingMeasure
Watch the same stakes the professionals are watching
Every tracked position priced at the quarter it was filed and diffed against the one before it: who added, who trimmed, who walked away.
Every position they holdMeasure
Interrogate the filing, not the internet
Ask anything about NEUROCRINE BIOSCIENCES INC's fundamentals. The assistant answers from its own filings and cites the figure, never a guess from the open web.

Create a free accountSee what the paid plans add

Free, no card, and it does not expire.